MedPath
NMPA Approval

Compound Sulfamethoxazole Injection

国药准字H13023409

November 3, 2020

Drug Information

复方磺胺甲噁唑注射液

注射剂

2ml:磺胺甲噁唑0.4g,甲氧苄啶80mg

化学药品

November 3, 2020

Company Information

Applicant Company

河北省三河市燕郊开发区迎宾北路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方磺胺甲噁唑注射液 - NMPA 批准文号 | MedPath